FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3170460689> ?p ?o ?g. }

• W3170460689 endingPage "e29" @default.
• W3170460689 startingPage "e21" @default.
• W3170460689 abstract "To evaluate the cost-effectiveness of tucatinib in human epidermal growth factor receptor 2 (HER2)-positive breast cancer (BC) patients with brain metastases (BMs) and the subgroup of active BMs from the United States (US) payer perspective.A 3-state Markov model was developed to compare the cost-effectiveness of 2 regimens in HER2-positive BC patients with BMs: (1) tucatinib, trastuzumab, and capecitabine (TTC); (2) placebo, trastuzumab, and capecitabine (PTC). And subgroup analysis of active BMs was also performed. Lifetime costs, quality-adjusted life years (QALYs), incremental cost-effectiveness ratio (ICER) and incremental net-health benefit (INHB) were estimated. The willingness-to-pay (WTP) threshold was $200,000/QALY. The robustness of the model was tested by sensitivity analyses. Additional scenario analysis was also performed.Compared with PTC, the ICER yielded by TTC was $418,007.01/QALY and the INHB was -1.08 QALYs in patients with BMs. In the subgroup of active BMs, the ICER and the INHB were $324,465.03/QALY and -0.71 QALY, respectively. The results were most sensitive to the cost of tucatinib. Probabilistic sensitivity analyses suggested that the cost-effective probability of TTC was low at the current WTP threshold in the patients with BMs and the subgroup of active BMs.Tucatinib is unlikely to be cost-effective in HER2-positive BC patients with BMs from the US payer perspective but shows better economics in patients with active BMs. Selecting a favorable population, reducing the price of tucatinib or offering appropriate drug assistance policies might be considerable options to optimize the cost-effectiveness of tucatinib." @default.
• W3170460689 created "2021-06-22" @default.
• W3170460689 creator A5002995123 @default.
• W3170460689 creator A5022876022 @default.
• W3170460689 creator A5023432391 @default.
• W3170460689 creator A5028928110 @default.
• W3170460689 creator A5031465004 @default.
• W3170460689 creator A5039898780 @default.
• W3170460689 creator A5040548754 @default.
• W3170460689 creator A5059392900 @default.
• W3170460689 creator A5069315417 @default.
• W3170460689 date "2022-01-01" @default.
• W3170460689 modified "2023-10-17" @default.
• W3170460689 title "Evaluation of Tucatinib in HER2-Positive Breast Cancer Patients With Brain Metastases: A United States-Based Cost-Effectiveness Analysis" @default.
• W3170460689 cites W1982967337 @default.
• W3170460689 cites W1991856603 @default.
• W3170460689 cites W2007198928 @default.
• W3170460689 cites W2036603224 @default.
• W3170460689 cites W2084572083 @default.
• W3170460689 cites W2168372454 @default.
• W3170460689 cites W2290821530 @default.
• W3170460689 cites W2397293125 @default.
• W3170460689 cites W2419312609 @default.
• W3170460689 cites W2512440162 @default.
• W3170460689 cites W2624590002 @default.
• W3170460689 cites W2806003597 @default.
• W3170460689 cites W2810914812 @default.
• W3170460689 cites W2883887224 @default.
• W3170460689 cites W2890708152 @default.
• W3170460689 cites W2893040167 @default.
• W3170460689 cites W2899395274 @default.
• W3170460689 cites W2902218997 @default.
• W3170460689 cites W2915456024 @default.
• W3170460689 cites W2941194391 @default.
• W3170460689 cites W2979291688 @default.
• W3170460689 cites W2995808512 @default.
• W3170460689 cites W3022747490 @default.
• W3170460689 cites W3030461309 @default.
• W3170460689 cites W3047417707 @default.
• W3170460689 cites W3119005666 @default.
• W3170460689 doi "https://doi.org/10.1016/j.clbc.2021.06.001" @default.
• W3170460689 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34238670" @default.
• W3170460689 hasPublicationYear "2022" @default.
• W3170460689 type Work @default.
• W3170460689 sameAs 3170460689 @default.
• W3170460689 citedByCount "4" @default.
• W3170460689 countsByYear W31704606892023 @default.
• W3170460689 crossrefType "journal-article" @default.
• W3170460689 hasAuthorship W3170460689A5002995123 @default.
• W3170460689 hasAuthorship W3170460689A5022876022 @default.
• W3170460689 hasAuthorship W3170460689A5023432391 @default.
• W3170460689 hasAuthorship W3170460689A5028928110 @default.
• W3170460689 hasAuthorship W3170460689A5031465004 @default.
• W3170460689 hasAuthorship W3170460689A5039898780 @default.
• W3170460689 hasAuthorship W3170460689A5040548754 @default.
• W3170460689 hasAuthorship W3170460689A5059392900 @default.
• W3170460689 hasAuthorship W3170460689A5069315417 @default.
• W3170460689 hasConcept C112930515 @default.
• W3170460689 hasConcept C121608353 @default.
• W3170460689 hasConcept C126322002 @default.
• W3170460689 hasConcept C143998085 @default.
• W3170460689 hasConcept C187960798 @default.
• W3170460689 hasConcept C2777909004 @default.
• W3170460689 hasConcept C2779786085 @default.
• W3170460689 hasConcept C2908647359 @default.
• W3170460689 hasConcept C3019080777 @default.
• W3170460689 hasConcept C44249647 @default.
• W3170460689 hasConcept C515549039 @default.
• W3170460689 hasConcept C526805850 @default.
• W3170460689 hasConcept C530470458 @default.
• W3170460689 hasConcept C71924100 @default.
• W3170460689 hasConcept C99454951 @default.
• W3170460689 hasConceptScore W3170460689C112930515 @default.
• W3170460689 hasConceptScore W3170460689C121608353 @default.
• W3170460689 hasConceptScore W3170460689C126322002 @default.
• W3170460689 hasConceptScore W3170460689C143998085 @default.
• W3170460689 hasConceptScore W3170460689C187960798 @default.
• W3170460689 hasConceptScore W3170460689C2777909004 @default.
• W3170460689 hasConceptScore W3170460689C2779786085 @default.
• W3170460689 hasConceptScore W3170460689C2908647359 @default.
• W3170460689 hasConceptScore W3170460689C3019080777 @default.
• W3170460689 hasConceptScore W3170460689C44249647 @default.
• W3170460689 hasConceptScore W3170460689C515549039 @default.
• W3170460689 hasConceptScore W3170460689C526805850 @default.
• W3170460689 hasConceptScore W3170460689C530470458 @default.
• W3170460689 hasConceptScore W3170460689C71924100 @default.
• W3170460689 hasConceptScore W3170460689C99454951 @default.
• W3170460689 hasFunder F4320321001 @default.
• W3170460689 hasFunder F4320321878 @default.
• W3170460689 hasIssue "1" @default.
• W3170460689 hasLocation W31704606891 @default.
• W3170460689 hasLocation W31704606892 @default.
• W3170460689 hasOpenAccess W3170460689 @default.
• W3170460689 hasPrimaryLocation W31704606891 @default.
• W3170460689 hasRelatedWork W1512398135 @default.
• W3170460689 hasRelatedWork W2001644930 @default.
• W3170460689 hasRelatedWork W2057711323 @default.
• W3170460689 hasRelatedWork W2334728600 @default.

• next